Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03234712
Title A Study Evaluating the Safety, Pharmacokinetics, and Anti-tumor Activity of ABBV-321 in Subjects With Advanced Solid Tumors Associated With Overexpression of the Epidermal Growth Factor Receptor (EGFR) or Its Ligands
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie
Indications

head and neck squamous cell carcinoma

lung squamous cell carcinoma

glioblastoma

colorectal cancer

Therapies

ABBV-321

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.